Changes in Hong Kong stocks | Nuocheng Jianhua (09969) rose more than 5% in early trading and recently signed a major agreement with Eli Lilly, and the company went further overseas

Zhitongcaijing · 2d ago

The Zhitong Finance App learned that Nuochengjianhua (09969) rose more than 5% in early trading. As of press release, it rose 3.69% to HK$14.62, with a turnover of HK$31.915 million.

According to the news, Nochengjianhua recently announced the signing of an R&D cooperation and licensing agreement with Eli Lilly. Nochengjianhua and Eli Lilly will carry out strategic cooperation in the field of innovative drug research and development. Relying on a proprietary drug discovery platform and deep research experience, Nochengjianhua will discover and develop up to 5 innovative target projects to address major unmet clinical needs.

According to reports, Eli Lilly will pay a down payment of up to 100 million US dollars and recent milestone payments. The total amount of potential R&D and commercialization milestone payments is about 3.25 billion US dollars. In addition, Nuochengjianhua has the right to charge a single-digit percentage of the annual net sales of licensed products. The signing of this agreement will help the company to use its own R&D platform to cooperate with Eli Lilly to develop innovative drugs, help further enhance the international competitiveness and influence of listed companies, and go further overseas.